First Time Loading...
S

Sema4 Holdings Corp
NASDAQ:SMFR

Watchlist Manager
Sema4 Holdings Corp
NASDAQ:SMFR
Watchlist
Price: 0.3431 USD -12.05% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

SMFR's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Sema4 Holdings Corp.is a patient centered health intelligence company. [ Read More ]

The intrinsic value of one SMFR stock under the Base Case scenario is 0.3624 USD. Compared to the current market price of 0.3431 USD, Sema4 Holdings Corp is Undervalued by 5%.

Key Points:
SMFR Intrinsic Value
Base Case
0.3624 USD
Undervaluation 5%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Sema4 Holdings Corp

Backtest SMFR Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SMFR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Sema4 Holdings Corp's business.

What risks and challenges
does Sema4 Holdings Corp face in the near future?

Summarize the latest earnings report
of Sema4 Holdings Corp.

Provide P/E
for Sema4 Holdings Corp and its competitors.

Financials

Balance Sheet Decomposition
Sema4 Holdings Corp

Current Assets 212.6m
Cash & Short-Term Investments 123.9m
Receivables 43.3m
Other Current Assets 45.3m
Non-Current Assets 278.3m
PP&E 84.3m
Intangibles 186.7m
Other Non-Current Assets 7.4m
Current Liabilities 144.3m
Accounts Payable 47.6m
Accrued Liabilities 53.7m
Other Current Liabilities 43m
Non-Current Liabilities 92.9m
Long-Term Debt 21.8m
Other Non-Current Liabilities 71.1m
Efficiency

Earnings Waterfall
Sema4 Holdings Corp

Revenue
234.7m USD
Cost of Revenue
-261.4m USD
Gross Profit
-26.8m USD
Operating Expenses
-640.9m USD
Operating Income
-667.7m USD
Other Expenses
118.7m USD
Net Income
-549m USD

Free Cash Flow Analysis
Sema4 Holdings Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SMFR Profitability Score
Profitability Due Diligence

Sema4 Holdings Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Positive 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
Negative ROE
16/100
Profitability
Score

Sema4 Holdings Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

SMFR Solvency Score
Solvency Due Diligence

Sema4 Holdings Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
49/100
Solvency
Score

Sema4 Holdings Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SMFR Price Targets Summary
Sema4 Holdings Corp

There are no price targets for SMFR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SMFR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SMFR Price
Sema4 Holdings Corp

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-97%
5Y 5Y
-96%
10Y 10Y
-96%
Annual Price Range
0.3431
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return -23.95%
Standard Deviation of Annual Returns 47.57%
Max Drawdown -99%
Shares Statistics
Market Capitalization 132.7m USD
Shares Outstanding 386 795 008
Percentage of Shares Shorted 1.85%

SMFR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Sema4 Holdings Corp

Country

United States of America

Industry

Health Care

Market Cap

132.7m USD

Dividend Yield

0%

Description

Sema4 Holdings Corp.is a patient centered health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,200 full-time employees. The company went IPO on 2020-09-04. The firm applies artificial intelligence and machine learning to clinical and genomic data to build models of human health and define individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate a complete understanding of disease and wellness and to provide science-driven solutions to pressing medical needs. Its Expanded Carrier Screen (ECS) is a carrier screen for inherited conditions. Its Noninvasive Prenatal Testing Solutions is a test that screens for autosomal and sex chromosome aneuploidies. Its Natalis Newborn Screening Solutions is a test of its screening portfolio allowing for detection of heritable conditions from pre-conception, pregnancy and childhood. The firm also includes Signal Precision Oncology Solutions.

Contact

CONNECTICUT
Stamford
333 Ludlow Street, North Tower, 8Th Floor
+16177808742.0
https://sema4.com/

IPO

2020-09-04

Employees

1 200

Officers

Exec. Chair of the Board
Mr. Jason Ryan
Consultant
Mr. Isaac Ro
CEO & Director
Ms. Katherine A. Stueland
Sr. VP of Operations & CFO
Mr. Kevin Feeley
VP of Technology Devel.
Mr. Robert Sebra Ph.D.
Chief Technology & Product Officer
Dr. Matthew Davis Ph.D.
Show More
Chief Science Officer
Dr. Gustavo Stolovitzky Ph.D.
Chief Compliance & Privacy Officer
Mr. Murali Mani
Chief People Officer
Ms. Karen White
Chief Transformation Officer
Mr. Kareem M. Saad
Show Less

See Also

Discover More
What is the Intrinsic Value of one SMFR stock?

The intrinsic value of one SMFR stock under the Base Case scenario is 0.3624 USD.

Is SMFR stock undervalued or overvalued?

Compared to the current market price of 0.3431 USD, Sema4 Holdings Corp is Undervalued by 5%.